Department of Chemical and Biological Engineering,
College of Engineering,
Nanovaccine Institute,
Department of Chemical and Biological Engineering, College of Engineering
Kathleen A. Ross has not added Biography.
If you are Kathleen A. Ross and would like to personalize this page please email our Author Liaison for assistance.
Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.
Advanced healthcare materials Feb, 2013 | Pubmed ID: 23184561
Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.
Journal of biomedical materials research. Part A Nov, 2014 | Pubmed ID: 24443139
Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours.
Advanced healthcare materials Jul, 2014 | Pubmed ID: 24520022
Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.
Nanoscale Nov, 2014 | Pubmed ID: 25285425
Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity.
International journal of nanomedicine , 2015 | Pubmed ID: 25565816
Nano-enabled delivery of diverse payloads across complex biological barriers.
Journal of controlled release : official journal of the Controlled Release Society Dec, 2015 | Pubmed ID: 26315817
Emerging trends in the immunotherapy of pancreatic cancer.
Cancer letters 03, 2018 | Pubmed ID: 29242097
pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles.
Biomacromolecules 03, 2018 | Pubmed ID: 29443509
Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections.
Frontiers in immunology , 2018 | Pubmed ID: 30233573
Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses.
The Journal of pharmacology and experimental therapeutics 09, 2019 | Pubmed ID: 30361239
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
Journal for immunotherapy of cancer 03, 2019 | Pubmed ID: 30890189
Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells.
Genes & cancer May, 2019 | Pubmed ID: 31258832
Effective mosaic-based nanovaccines against avian influenza in poultry.
Vaccine 08, 2019 | Pubmed ID: 31300285
Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.
Nanomedicine : nanotechnology, biology, and medicine 10, 2019 | Pubmed ID: 31319179
Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.
Current topics in microbiology and immunology Nov, 2020 | Pubmed ID: 33165869
Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.
Journal of immunology (Baltimore, Md. : 1950) May, 2021 | Pubmed ID: 33827894
M. M. Hasibuzzaman1,2,
Kathleen A. Ross3,4,
Aliasger K. Salem1,4,5,6,
Balaji Narasimhan3,4,
Andrean L. Simons1,2,3,5,6,7
1Interdisciplinary Graduate Program in Human Toxicology, University of Iowa,
2Department of Pathology, University of Iowa,
3Department of Chemical and Biological Engineering, College of Engineering, Iowa State University,
4Nanovaccine Institute, Iowa State University,
5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy, University of Iowa,
6Holden Comprehensive Cancer Center, University of Iowa,
7Department of Oral Pathology, Radiology and Medicine, College of Dentistry, University of Iowa
Copyright © 2024 MyJoVE Corporation. 판권 소유